GlaxoSmithKline PLC (NYSE:GSK)
| 36.07 Delayed Data As of 4:00pm ET |  -0.58 / -1.58%Today’s Change | 33.26 Today|||52-Week Range 43.18 | -1.98% Year-to-Date |
Latest GSK News | Press Releases
Today’s Trading
| Previous close | 36.65 |
| Today’s open | 36.04 |
| Day’s range | 36.02 - 36.19 |
| Volume | 7,151,995 |
| Average volume (3 months) | 5,493,117 |
| Market cap | $92.2B |
Data as of 4:00pm ET, 04/12/2021
Growth & Valuation
| Earnings growth (last year) | +23.68% |
| Earnings growth (this year) | -12.29% |
| Earnings growth (next 5 years) | +4.33% |
| Revenue growth (last year) | +1.55% |
| P/E ratio | 11.5 |
| Price/Sales | 2.12 |
| Price/Book | 4.58 |
Competitors
Data as of 4:00pm ET, 04/12/2021
Financials
| Next reporting date | April 28, 2021 |
| EPS forecast (this quarter) | $0.66 |
| Annual revenue (last year) | $43.7B |
| Annual profit (last year) | $7.4B |
| Net profit margin | 16.86% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Middlesex, Greater London |
Forecasts
